QMS

MAH/CDMO



Set Contract Module
0  Customer Requirement Specification(CRS) <More...>
A  Contract IMP to Test&Manufacture separately (Phase I&II) <More...>
B  Contract Excipients to Test&Re-process (Used in Sterile MPs) <More...>
C  Contract Labelling RLD of IMP (for Clinic Trial) <More...>
D  Contract Manufacture without Labelling AMP vial (for Commercial) <More...>
 
 
Date CDMO/CMO Series
202404  3 Key Trends Shaping The CDMO Industry In 2024 And Beyond <More...>
202403  Is your API ready for scale up?<More...>
202402  Effective Quality CDMO Contracting <More...>
202401  How To Select An API Partner For Strategic Success <More...>
202312  Make The Service Agreement Work For You And Your CDMO <More...>
202311  Industry Trends of CDMO Outsouring <More...>
202310  10 Ways to Improve Your CDMO Partnerships <More...>
202309  6 Tips for Successful Drug Discovery Teamwork <More...>
202308  Use Of Consultants For CDMO Selection <More...>
202306  The opportunity and challenge of biomanufacturing <More...>
202303  CDMOs And CCS The Span Of Oversight In EU GMP Annex 1 Compliance <More...>
202302  5 Steps To CDMO Selection <More...>
202301  Preparing For Your CDMO Selection Process <More...>
202212  Have CDMO Selection Criteria Changed Over the Past Five Years <More...>
202211  QA and your CDMO <More...>
202210  Is Selecting A CDMO Based On Contract Price Really Saving You Money In The Long Run <More...>
202209  Highly Potent API Market Outlook <More...>

   
Date Technology transfer Series
202307  Manufacturing Process Transfer <More...>
202305  Analytical Method Transfer(AMT) <More...>
202304  Manufacturing Process Transfer(QRM Application to Start-Up Evaluation) <More...>

​